Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 178

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial

Bellon, Gabriel, Michel-Calemard, Laurence, Thouvenot, Danièle, Jagneaux, Véronique, Poitevin, Françoise, Malcus, Christophe, Accart, Nathalie, Layani, Marie Pierre, Aymard, Michèle, Bernon, Hélène, Bienvenu, Jacques, Courtney, Michael, Döring, Gerd, Gilly, Bernard, Gilly, Robert, Lamy, Didier, Levrey, Hélène, Morel, Yves, Paulin, Christian, Perraud, Frédéric, Rodillon, Laurence, Sené, Claude, So, Satta, Touraine-Moulin, Françoise, Schatz, Christian, Pavirani, Andrea · 1997 · Human Gene Therapy

Abstract

Ad CFTR, a replication-deficient adenovirus expressing the human cystic fibrosis transmembrane conductance regulator (CFTR), was administered by aerosolization in a single escalating dose to three pairs (cohorts) of cystic fibrosis (CF) patients. Buffer only was administered to the nose and lungs 9-14 days before nasal instillation of virus followed the day after by aerosolization of Ad CFTR to the lung. Nasal doses (defined in terms of viral plaque forming units, pfu) were 10(5), 10(7), and 4 x 10(8), whereas aerosolized doses were 10(7), 10(8), 5.4 x 10(8) for each cohort, respectively. No acute toxic effects were observed in the first 4 weeks after virus treatment. Shedding of infectious Ad CFTR was never detected, whereas detection of vector DNA sequences and CFTR expression demonstrated DNA transfer to the nose and airways of patients. No significant deviations in immunological and inflammatory parameters were observed in serum and in bronchoalveolar lavage (BAL). Importantly, for all patients, the serum anti-adenovirus antibody levels did not change significantly from baseline and no antibodies against adenovirus were found in BAL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.1997.8.1-15

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 178

Metadata

Authors
Bellon, G., Michel-Calemard, L., Thouvenot, D., Jagneaux, V., Poitevin, F., Malcus, C., Accart, N., Layani, M. P., Aymard, M., Bernon, H., Bienvenu, J., Courtney, M., Döring, G., Gilly, B., Gilly, R., Lamy, D., Levrey, H., Morel, Y., Paulin, C., Perraud, F., Rodillon, L., Sené, C., So, S., Touraine-Moulin, F., Schatz, C., & Pavirani, A.
Venue
Human Gene Therapy
Published
1997-01
Volume
8
Issue
1
Pages
15-25
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2075350162
Cited by
178
References
2
FWCI
19.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial. https://app.cochat.ai/papers/10.1089/hum.1997.8.1-15
The paper
Bellon, G., Michel-Calemard, L., Thouvenot, D., Jagneaux, V., Poitevin, F., Malcus, C., Accart, N., Layani, M. P., Aymard, M., Bernon, H., Bienvenu, J., Courtney, M., Döring, G., Gilly, B., Gilly, R., Lamy, D., Levrey, H., Morel, Y., Paulin, C., . . . Pavirani, A. (1997). Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial. Human Gene Therapy. https://doi.org/10.1089/hum.1997.8.1-15

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.